GripAble joins ABHI US Accelerator
We are thrilled to announce that GripAble has joined the ABHI US Accelerator, an international expansion programme led by the Association of British Healthtech Industries (ABHI).
The Accelerator helps UK health tech companies to strengthen their US strategy, de-risk market entry and grow their US business.
Despite current international travel restrictions, the 2021 programme will see ABHI’s busiest calendar of activity to date. A monthly learning series will provide a deep dive into key topics, looking at how the US organises healthcare, with expert briefings on areas including FDA approval, compliance and technology adoption processes. A series of virtual trade missions to states including Texas, California and Tennessee will enable a series of “Dragons’ Den” style pitch sessions, all designed to connect UK businesses to an extensive network of US hospital, clinical and supply chain leaders.
The programme also provides GripAble with full use of ABHI’s dedicated workspace and office at the Dell Medical School in Austin, with access to their facilities and the support of senior faculty.
Danielle Richards, GripAble Commercial Manager, said:
“Since the commercial launch of GripAble in spring 2020, we now have hundreds of devices in use in hospitals, clinics and the community across more than 15 countries. We are so pleased to have the exciting opportunity to grow GripAble in the US – the ABHI US Accelerator provides us with a valuable ecosystem of clinicians, investors and mentors to help us develop our presence in the all-important US market.”
Philip Kennedy, Chair of ABHI, said:
“The ABHI US Accelerator will offer GripAble a unique opportunity to collaborate in the world’s largest HealthTech market. The programme will support promising HealthTech innovation, whilst seeking to develop value-based healthcare for the benefit of patients on both sides of the Atlantic.”
GripAble is developing an ecosystem of proprietary sensor-based devices and an engaging software platform, providing remote physical assessment and therapy for people with upper limb impairments (e.g. caused by neurological damage or orthopaedic trauma). The system allows for therapy teams to remotely manage multiple individuals at a time, and empowers patients to then self-manage their condition. This allows for much of the therapy that now takes place in hospitals to be performed at-home.
GripAble’s first product is a digital handgrip device that connects wirelessly to their mobile therapy app allowing individuals with hand, wrist and arm impairment to complete objective assessments and engaging therapy activities. A study at Imperial College London has shown an eightfold increase in exercise among patients given the opportunity to use the device, with example case studies emerging of individuals achieving fourfold increases in strength after sustained use.